Ishaan Shandil
About Ishaan Shandil
Ishaan Shandil is the Associate Director of Global Product Development and Supply at Bristol Myers Squibb, with over 14 years of experience in the biopharma industry.
Title
Ishaan Shandil is currently serving as Associate Director, Global Product Development and Supply at Bristol Myers Squibb located in the Greater Boston Area.
Professional Experience at Merck
Prior to his current role, Ishaan Shandil accumulated extensive experience at Merck. He worked there as a Senior Scientist in Engineering in 2015-2016, as a Senior Scientist in Molecular Discovery from 2012 to 2015, and as a Staff/Research Biochemical Engineer from 2008 to 2012. During his tenure at Merck in the Greater Boston Area, he honed his skills in various scientific and engineering disciplines.
Education and Expertise
Ishaan Shandil has a robust educational background that includes an MBA from The University of Chicago Booth School of Business (2019-2021) and multiple certificates from HBX | Harvard Business School, including Disruptive Strategy with Clayton Christensen (2018) and Core: Credential of Readiness (2015). He also holds a Master of Science from the University of California, Irvine (2007-2008) and a Bachelor in Technology from Kurukshetra University (2002-2006).
Early Career and International Experience
Before joining Merck, Ishaan Shandil served as a Scientific Officer in Vaccine Production at Panacea Biotec Ltd in India from 2006 to 2007. This role gave him valuable industry insights and foundational expertise in vaccine production.
Community Involvement
Ishaan Shandil actively volunteers at the Humane Society for Greater Nashua, where he contributes to community welfare. This demonstrates his commitment to giving back to the community.
Experience in Leading High-Performance Teams
With over 14 years of industry experience, Ishaan Shandil has proven his capability to lead high-performance teams in R&D and Technical Operations. His strong track record in creating and delivering business value in the biopharma industry underscores his expertise.